Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases

被引:329
作者
Ohnishi, H
Yokoyama, A [1 ]
Kondo, K
Hamada, H
Abe, M
Nishimura, K
Hiwada, K
Kohno, N
机构
[1] Ehime Univ, Sch Med, Dept Internal Med 2, Ehime 7910295, Japan
[2] Hiroshima Univ, Sch Med, Dept Internal Med 2, Hiroshima, Japan
[3] Ehime Natl Hosp, Dept Resp Med, Ehime, Japan
关键词
interstitial lung diseases; serum marker; KL-6; surfactant protein; monocyte chemoattractant protein-1;
D O I
10.1164/ajrccm.165.3.2107134
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
KL-6, surfactant protein (SP)-A, SP-D, and monocyte chemoattractant protein-1 (MCP-1) are reported to be sensitive markers for interstitial lung diseases (ILD). However, each marker has been studied independently. The aim of this study was a comparative analysis of the diagnostic values of these markers. Subjects consisted of 33 patients with ILD (21 cases of idiopathic pulmonary fibrosis and 12 associated with collagen vascular diseases) and 82 control subjects (12 cases of bacterial pneumonia and 70 healthy volunteers). Receiver operating characteristic curves revealed that KL-6 was superior to the other markers. The cut-off levels for these markers that resulted in the highest diagnostic accuracy were determined to be 465 U/ml for KL-6, 48.2 ng/ml for SP-A, 116 ng/ml for SP-D, and 1080 pg/ml for MCP-1. The sensitivity, specificity, and diagnostic accuracy were 93.9%, 96.3%, and 95.7% for KL-6; 81.8%, 86.6%, and 85.2% for SP-A; 69.7%, 95.1%, and 87.8% for SP-D; and 51.5%, 92.7%, and 80.9% for MCP-1; respectively. The serum levels of SIP-A and SP-D, but not of KL-6, were significantly higher in patients with bacterial pneumonia than in healthy volunteers. These results suggest that of the markers studied, KL-6 is the best serum marker for ILD.
引用
收藏
页码:378 / 381
页数:4
相关论文
共 23 条
  • [1] [Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
  • [2] EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 MESSENGER-RNA IN HUMAN IDIOPATHIC PULMONARY FIBROSIS
    ANTONIADES, HN
    NEVILLEGOLDEN, J
    GALANOPOULOS, T
    KRADIN, RL
    VALENTE, AJ
    GRAVES, DT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) : 5371 - 5375
  • [3] ALVEOLITIS AND COLLAPSE IN THE PATHOGENESIS OF PULMONARY FIBROSIS
    BURKHARDT, A
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02): : 513 - 524
  • [4] KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromised hosts
    Hamada, H
    Kohno, N
    Yokoyama, A
    Hirasawa, Y
    Hiwada, K
    Sakatani, M
    Ueda, E
    [J]. INTERNAL MEDICINE, 1998, 37 (03) : 307 - 310
  • [5] Lung epithelium-specific proteins - Characteristics and potential applications as markers
    Hermans, C
    Bernard, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (02) : 646 - 678
  • [6] KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts
    Hirasawa, Y
    Kohno, N
    Yokoyama, A
    Inoue, Y
    Abe, M
    Hiwada, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (04) : 501 - 507
  • [7] PULMONARY SURFACTANT PROTEIN-D IN SERA AND BRONCHOALVEOLAR LAVAGE FLUIDS
    HONDA, Y
    KUROKI, Y
    MATSUURA, E
    NAGAE, H
    TAKAHASHI, H
    AKINO, T
    ABE, S
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) : 1860 - 1866
  • [8] EVALUATION OF SERUM KL-6 LEVELS IN PATIENTS WITH PULMONARY TUBERCULOSIS
    INOUE, Y
    NISHIMURA, K
    SHIODE, M
    AKUTSU, H
    HAMADA, H
    FUJIOKA, S
    FUJINO, S
    YOKOYAMA, A
    KOHNO, N
    HIWADA, K
    [J]. TUBERCLE AND LUNG DISEASE, 1995, 76 (03): : 230 - 233
  • [9] CIRCULATING ANTIGEN-KL-6 AND LACTATE-DEHYDROGENASE FOR MONITORING IRRADIATED PATIENTS WITH LUNG-CANCER
    KOHNO, N
    HAMADA, H
    FUJIOKA, S
    HIWADA, K
    YAMAKIDO, M
    AKIYAMA, M
    [J]. CHEST, 1992, 102 (01) : 117 - 122
  • [10] Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia
    Kohno, N
    Yokoyama, A
    Hirasawa, Y
    Kondo, K
    Fujino, S
    Abe, M
    Hiwada, K
    [J]. RESPIRATORY MEDICINE, 1997, 91 (09) : 558 - 561